Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

271 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The future of sarcoma treatment.
Biermann JS, Baker LH. Biermann JS, et al. Among authors: baker lh. Semin Oncol. 1997 Oct;24(5):592-7. Semin Oncol. 1997. PMID: 9344326 Review.
Randomized phase II evaluation of 6 g/m2 of ifosfamide plus doxorubicin and granulocyte colony-stimulating factor (G-CSF) compared with 12 g/m2 of ifosfamide plus doxorubicin and G-CSF in the treatment of poor-prognosis soft tissue sarcoma.
Worden FP, Taylor JM, Biermann JS, Sondak VK, Leu KM, Chugh R, McGinn CJ, Zalupski MM, Baker LH. Worden FP, et al. Among authors: baker lh. J Clin Oncol. 2005 Jan 1;23(1):105-12. doi: 10.1200/JCO.2005.05.108. J Clin Oncol. 2005. PMID: 15625365 Clinical Trial.
Chordoma: the nonsarcoma primary bone tumor.
Chugh R, Tawbi H, Lucas DR, Biermann JS, Schuetze SM, Baker LH. Chugh R, et al. Among authors: baker lh. Oncologist. 2007 Nov;12(11):1344-50. doi: 10.1634/theoncologist.12-11-1344. Oncologist. 2007. PMID: 18055855 Free article. Review.
Bone cancer clinical practice guidelines.
Biermann JS, Baker LH, Benjamin R, Brigman B, Chow W, Conrad EU 3rd, Frassica D, Frassica FJ, George S, Healey JH, Heck R, Letson GD, Mayerson J, Neff J, O'Donnell RJ, Randall RL, Santana V, Satcher RL, Schmidt RG, Siegel HJ, Wong MK, Yasko AW; National Comprehensive Cancer Network. Biermann JS, et al. Among authors: baker lh. J Natl Compr Canc Netw. 2005 Mar;3(2):124-40. J Natl Compr Canc Netw. 2005. PMID: 19817025 No abstract available.
A randomised, open-label, phase II study of neo/adjuvant doxorubicin and ifosfamide versus gemcitabine and docetaxel in patients with localised, high-risk, soft tissue sarcoma.
Davis EJ, Chugh R, Zhao L, Lucas DR, Biermann JS, Zalupski MM, Feng M, Wong SL, Jacobson J, Zyczynski L, Reinke D, Metko G, Baker LH, Schuetze SM. Davis EJ, et al. Among authors: baker lh. Eur J Cancer. 2015 Sep;51(13):1794-802. doi: 10.1016/j.ejca.2015.05.010. Epub 2015 Jun 9. Eur J Cancer. 2015. PMID: 26066736 Clinical Trial.
271 results